SALE
市場調查報告書
商品編碼
1021831

鼻腔給藥的全球市場:各藥物類型,劑型,容器類型,用量設定,治療用途,終端用戶,流通管道,地區,競爭,預測和機會(2026年)

Global Nasal Drug Delivery Market, By Drug Type, By Dosage Form, By Container Type, By Basis of System, By Therapeutic Application, By End User, By Distribution Channel, By Region, Competition, Forecast & Opportunities, 2026

出版日期: | 出版商: TechSci Research | 英文 116 Pages | 商品交期: 2-3個工作天內

價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

  • 全貌
  • 簡介
  • 目錄
簡介

全球鼻腔給藥的市場規模,在預測期間內預計以11.67%的年複合成長率成長,預計2026年達到1,239億2,000萬美元。

被該市場的主要的成長要素,是自我給藥的普及與居家醫療設備的需求高漲。再加上先進鼻腔給藥設備開發,其有效性與容易的給藥特性促進市場成長。

由於鼻腔給藥的認識度提高和患者的偏好高漲,今後5年市場預計大幅被成長。對還有醫療保健領域的支出增加,及各國政府著重研究開發活動的促進,也支撐該市場的成長。但,鼻腔用粉和鼻腔用噴霧的用過量造成的併發症,有抑制該市場的成長的可能性。

本報告提供全球鼻腔給藥市場的相關調查,市場規模和預測,佔有率,COVID-19的影響,成長要素和課題,各藥物類型、劑型、容器類型、用量設定、治療用途、終端用戶、流通管道、地區的市場分析,競爭情形,主要企業的簡介等資訊。

目錄

第1章 產品概要

第2章 調查手法

第3章 COVID-19對全球鼻腔給藥市場的影響

第4章 摘要整理

第5章 客戶的迴響

  • 品牌認知度
  • 購買決策的影響因素
  • 患者滿意度分析
  • 未滿足需求與課題

第6章 全球鼻腔給藥市場預測

  • 市場規模與預測
    • 各銷售額
  • 市場佔有率與預測
    • 各藥物類型(抗組織胺藥,皮質類固醇,麻醉劑,抗生素,止痛藥,其他)
    • 各劑型(噴霧,滴液,粉末,凝膠,軟膏)
    • 各容器類型(非加壓容器,加壓容器)
    • 各用量設定(定量,多回用量,單位用量)
    • 各治療用途(氣喘,慢性阻塞性肺病(COPD),鼻炎,囊狀纖維化症,鼻塞)
    • 各終端用戶(居家醫療設定,醫院,診療所)
    • 各流通管道(零售藥局,醫院藥局,線上)
    • 各企業(2020)
    • 各地區
  • 產品市場地圖

第7章 北美的鼻腔給藥市場預測

  • 市場規模與預測
    • 各銷售額
  • 市場佔有率與預測
    • 各藥物類型
    • 各劑型
    • 各容器類型
    • 各用量設定
    • 各治療用途
    • 各終端用戶
    • 各流通管道
    • 各國
  • 北美:各國分析
    • 美國鼻腔給藥市場預測
    • 墨西哥的鼻腔給藥市場預測
    • 加拿大的鼻腔給藥市場預測

第8章 歐洲的鼻腔給藥市場預測

  • 市場規模與預測
    • 各銷售額
  • 市場佔有率與預測
    • 各藥物類型
    • 各劑型
    • 各容器類型
    • 各用量設定
    • 各治療用途
    • 各終端用戶
    • 各流通管道
    • 各國
  • 歐洲:各國分析
    • 德國的鼻腔給藥市場預測
    • 法國的鼻腔給藥市場預測
    • 英國的鼻腔給藥市場預測
    • 義大利的鼻腔給藥市場預測
    • 西班牙的鼻腔給藥市場預測

第9章 亞太地區的鼻腔給藥市場預測

  • 市場規模與預測
    • 各銷售額
  • 市場佔有率與預測
    • 各藥物類型
    • 各劑型
    • 各容器類型
    • 各用量設定
    • 各治療用途
    • 各終端用戶
    • 各流通管道
    • 各國
  • 亞太地區:各國分析
    • 日本的鼻腔給藥市場預測
    • 中國的鼻腔給藥市場預測
    • 印度的鼻腔給藥市場預測
    • 韓國的鼻腔給藥市場預測
    • 澳洲的鼻腔給藥市場預測

第10章 南美鼻腔給藥市場預測

  • 市場規模與預測
    • 各銷售額
  • 市場佔有率與預測
    • 各藥物類型
    • 各劑型
    • 各容器類型
    • 各用量設定
    • 各治療用途
    • 各終端用戶
    • 各流通管道
    • 各國
  • 南美:各國分析
    • 巴西的鼻腔給藥市場預測
    • 阿根廷的鼻腔給藥市場預測
    • 哥倫比亞的鼻腔給藥市場預測

第11章 中東及非洲的鼻腔給藥市場預測

  • 市場規模與預測
    • 各銷售額
  • 市場佔有率與預測
    • 各藥物類型
    • 各劑型
    • 各容器類型
    • 各用量設定
    • 各治療用途
    • 各終端用戶
    • 各流通管道
    • 各國
  • 中東、非洲:各國分析
    • 南非的鼻腔給藥市場預測
    • 沙烏地阿拉伯的鼻腔給藥市場預測
    • 阿拉伯聯合大公國的鼻腔給藥市場預測

第12章 市場動態

  • 成長要素
  • 課題

第13章 市場趨勢

第14章 競爭情形

  • 競爭預測
  • 企業簡介(主要企業)
    • GlaxoSmithKline Plc.
    • Pfizer, Inc.
    • AstraZeneca PLC
    • Novartis AG
    • Becton Dickson & Company
    • Promius Pharma LLC
    • 3M Company
    • Johnson & Johnson Services, Inc.
    • Sanofi S.A.
    • Merck & Co., Inc.
    • Cadila Pharmaceuticals Ltd.
    • Aegis Therapeutics, LLC
    • B.F. Ascher & Company, Inc.
    • ENT Technologies Pty. Ltd.
    • AptarGroup, Inc.

第15章 策略性建議

第16章 關於本公司&免責聲明

目錄
Product Code: 5174

Global nasal drug delivery market is expected to grow at CAGR of 11.67% during the forecast period and is projected to reach USD123.92 billion by 2026 owing to the growing cases of respiratory problems such as asthma, paranasal sinuses, nasal infection, and others along with surging demand for non-invasive techniques and less painful treatments. Nasal drug delivery devices provide self-medication, which does not require patients to visit the doctor. The growing adoption of self-administration practices and demand for home healthcare devices are acting as key growth drivers for the growth of the global nasal drug delivery market. Furthermore, development of advanced nasal drug delivery devices and their efficacy and easy administration properties are propeling the market growth. With growing awareness and growing patient preference for nasal products, the market is poised to witness substantial growth in the next five years.

Moreover, increasing expenditure on healthcare sector and various governments' focus on promoting R&D activities are supporting the growth of the global nasal drug delivery market. However, the market is also facing some restraints. Complications related to the over usage of nasal powders and nasal sprays are likely to hamper the growth of the global nasal drug delivery market.

Global nasal drug delivery market can be segmented based on drug type, dosage form, container type, basis of system, therapeutic applications, end user, distribution channel and region. Based on container type, the market can be segmented into non-pressurized containers and pressurized containers. Among them, the non-pressurized containers are expected to undergo the fastest CAGR during the forecast period as they are mostly used in nasal sprays. Thus, the increasing demand for nasal sprays and growing prevalence of chronic diseases like asthma and diabetes are expected to contribute to the dominant share of non-pressurized containers through 2026.

Regionally, North America dominated the global nasal drug delivery market in 2020 and is further expected to continue its dominance during the forecast period. Increasing cases of respiratory disorders and presence of key market players are making North America a favorable market for nasal drug delivery. However, Asia Pacific is anticipated to undergo the fastest CAGR during the forecast period owing to rising awareness and prevalence of chronic and respiratory disorders in the region.

Major companies operating in the global nasal drug delivery market include GlaxoSmithKline Plc., Pfizer, Inc., AstraZeneca PLC, Novartis AG, Becton Dickson & Company, Promius Pharma LLC, 3M COMPANY, Johnson & Johnson Services, Inc., Sanofi S.A., Merck & Co., Inc., Cadila Pharmaceuticals Ltd., Aegis Therapeutics, LLC, B.F. Ascher & Company, Inc., ENT Technologies Pty. Ltd. and AptarGroup, Inc., among others. Key market players are undergoing growth strategies like joint ventures and new product launches to strengthen their position in the global market.

Years considered for this report:

Historical Years: 2016-2019

Base Year: 2020

Estimated Year: 2021

Forecast Period: 2022-2026

Objective of the Study:

  • To analyze and forecast the market size of the global nasal drug delivery market from 2016 to 2020.
  • To estimate and forecast the market size of the global nasal drug delivery market from 2021 to 2026.
  • To forecast global nasal drug delivery market based on drug type, dosage form, container type, basis of system, delivery technologies, therapeutic applications, end user, distribution channel, company and regional distribution.
  • To identify drivers and challenges for global nasal drug delivery market.
  • To examine competitive developments such as expansions, new product launches, mergers & acquisitions etc. in global nasal drug delivery market.
  • To identify and analyze the profile of leading players operating in the global nasal drug delivery market.

TechSci Research performed both primary as well as exhaustive secondary research for this study. Initially, TechSci Research sourced a list of nasal drug delivery market devices manufacturers across the globe. Subsequently, TechSci Research conducted primary research surveys with the identified companies. While interviewing, the respondents were also enquired about their competitors. Through this technique, TechSci Research could include the manufacturers which could not be identified due to the limitations of secondary research.

TechSci Research calculated global nasal drug delivery market size using a bottom-up approach, where data for various end user industries and its application across various product types were recorded and forecast for the future years. TechSci Research sourced these values from the industry experts and company representatives and externally validated through analysing historical data of these product types and applications for getting an appropriate, overall market size. Various secondary sources such as company websites, news articles, press releases, company annual reports, investor presentations and financial reports were also used by TechSci Research.

Key Target Audience:

  • Nasal Drug Delivery Market device manufacturers/ companies/ partners
  • Hospital Pharmacies/ Retail Pharmacies
  • Government bodies such as regulating authorities and policy makers
  • Organizations, industry associations, forums and alliances related to Nasal Drug Delivery Market
  • Market research and consulting firms

The study is useful in providing answers to several critical questions that are important for the industry stakeholders such as Nasal Drug Delivery Market device manufacturing companies and end users etc., besides allowing them in strategizing investments and capitalizing on market opportunities.

Report Scope:

In this report, global nasal drug delivery market has been segmented into following categories, in addition to the industry trends which have also been detailed below:

  • Global Nasal Drug Delivery Market, By Drug Type:

Antihistamines

Corticosteroids

Anesthetics

Antibiotics

Pain Relief Drugs

Others

  • Global Nasal Drug Delivery Market, By Dosage Form:

Sprays

Drops

Powder

Gels & Ointments

  • Global Nasal Drug Delivery Market, By Container Type:

Non-pressurized Containers

Pressurized Containers

  • Global Nasal Drug Delivery Market, By Basis of System:

Metered Dose

Multi-Dose

Unit Dose

  • Global Nasal Drug Delivery Market, By Therapeutic Applications:

Asthma

Chronic Obstructive Pulmonary Disease (COPD)

Rhinitis

Cystic Fibrosis

Nasal Congestion

  • Global Nasal Drug Delivery Market, By End User:

Home Care Settings

Hospitals

Clinics

  • Global Nasal Drug Delivery Market, By Distribution Channel:

Retail Pharmacies

Hospital Pharmacies

Online

  • Global Nasal Drug Delivery Market, By Region:

North America

i. United States

ii. Mexico

iii. Canada

Europe

i. Germany

ii. France

iii. United Kingdom

iv. Italy

v. Spain

Asia-Pacific

i. Japan

ii. China

iii. India

iv. South Korea

v. Australia

South America

i. Brazil

ii. Argentina

iii. Colombia

Middle East & Africa

i. South Africa

ii. Saudi Arabia

iii. UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in global nasal drug delivery market.

Available Customizations:

With the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Profit Margin Analysis

  • Profit margin analysis in case of direct and indirect sales channel.

Table of Contents

1. Product Overview

2. Research Methodology

3. Impact of COVID-19 on Global Nasal Drug Delivery Market

4. Executive Summary

5. Voice of Customer

  • 5.1. Brand Awareness
  • 5.2. Factors Influencing Purchase Decision
  • 5.3. Patient Satisfaction Analysis
  • 5.4. Unmet Need and Challenges

6. Global Nasal Drug Delivery Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Drug Type (Antihistamines, Corticosteroids, Anesthetics, Antibiotics, Pain Relief Drugs, Others)
    • 6.2.2. By Dosage Form (Sprays, Drops, Powder, Gels & Ointments)
    • 6.2.3. By Container Type (Non-pressurized Containers, Pressurized Containers)
    • 6.2.4. By Basis of System (Metered Dose, Multi-Dose, Unit Dose)
    • 6.2.5. By Therapeutic Applications (Asthma, Chronic Obstructive Pulmonary Disease (COPD), Rhinitis, Cystic Fibrosis, Nasal Congestion)
    • 6.2.6. By End User (Home Care Settings, Hospitals & Clinics)
    • 6.2.7. By Distribution Channel (Retail Pharmacies, Hospital Pharmacies, Online)
    • 6.2.8. By Company (2020)
    • 6.2.9. By Region
  • 6.3. Product Market Map

7. North America Nasal Drug Delivery Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Drug Type
    • 7.2.2. By Dosage Form
    • 7.2.3. By Container Type
    • 7.2.4. By Basis of System
    • 7.2.5. By Therapeutic Applications
    • 7.2.6. By End User
    • 7.2.7. By Distribution Channel
    • 7.2.8. By Country
  • 7.3. North America: Country Analysis
    • 7.3.1. United States Nasal Drug Delivery Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Drug Type
        • 7.3.1.2.2. By Dosage Form
        • 7.3.1.2.3. By Container Type
        • 7.3.1.2.4. By Basis of System
        • 7.3.1.2.5. By Therapeutic Applications
        • 7.3.1.2.6. By End User
        • 7.3.1.2.7. By Distribution Channel
    • 7.3.2. Mexico Nasal Drug Delivery Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Drug Type
        • 7.3.2.2.2. By Dosage Form
        • 7.3.2.2.3. By Container Type
        • 7.3.2.2.4. By Basis of System
        • 7.3.2.2.5. By Therapeutic Applications
        • 7.3.2.2.6. By End User
        • 7.3.2.2.7. By Distribution Channel
    • 7.3.3. Canada Nasal Drug Delivery Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Drug Type
        • 7.3.3.2.2. By Dosage Form
        • 7.3.3.2.3. By Container Type
        • 7.3.3.2.4. By Basis of System
        • 7.3.3.2.5. By Therapeutic Applications
        • 7.3.3.2.6. By End User
        • 7.3.3.2.7. By Distribution Channel

8. Europe Nasal Drug Delivery Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Drug Type
    • 8.2.2. By Dosage Form
    • 8.2.3. By Container Type
    • 8.2.4. By Basis of System
    • 8.2.5. By Therapeutic Applications
    • 8.2.6. By End User
    • 8.2.7. By Distribution Channel
    • 8.2.8. By Country
  • 8.3. Europe: Country Analysis
    • 8.3.1. Germany Nasal Drug Delivery Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Drug Type
        • 8.3.1.2.2. By Dosage Form
        • 8.3.1.2.3. By Container Type
        • 8.3.1.2.4. By Basis of System
        • 8.3.1.2.5. By Therapeutic Applications
        • 8.3.1.2.6. By End User
        • 8.3.1.2.7. By Distribution Channel
    • 8.3.2. France Nasal Drug Delivery Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Drug Type
        • 8.3.2.2.2. By Dosage Form
        • 8.3.2.2.3. By Container Type
        • 8.3.2.2.4. By Basis of System
        • 8.3.2.2.5. By Therapeutic Applications
        • 8.3.2.2.6. By End User
        • 8.3.2.2.7. By Distribution Channel
    • 8.3.3. United Kingdom Nasal Drug Delivery Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Drug Type
        • 8.3.3.2.2. By Dosage Form
        • 8.3.3.2.3. By Container Type
        • 8.3.3.2.4. By Basis of System
        • 8.3.3.2.5. By Therapeutic Applications
        • 8.3.3.2.6. By End User
        • 8.3.3.2.7. By Distribution Channel
    • 8.3.4. Italy Nasal Drug Delivery Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Drug Type
        • 8.3.4.2.2. By Dosage Form
        • 8.3.4.2.3. By Container Type
        • 8.3.4.2.4. By Basis of System
        • 8.3.4.2.5. By Therapeutic Applications
        • 8.3.4.2.6. By End User
        • 8.3.4.2.7. By Distribution Channel
    • 8.3.5. Spain Nasal Drug Delivery Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Drug Type
        • 8.3.5.2.2. By Dosage Form
        • 8.3.5.2.3. By Container Type
        • 8.3.5.2.4. By Basis of System
        • 8.3.5.2.5. By Therapeutic Applications
        • 8.3.5.2.6. By End User
        • 8.3.5.2.7. By Distribution Channel

9. Asia-Pacific Nasal Drug Delivery Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Drug Type
    • 9.2.2. By Dosage Form
    • 9.2.3. By Container Type
    • 9.2.4. By Basis of System
    • 9.2.5. By Therapeutic Applications
    • 9.2.6. By End User
    • 9.2.7. By Distribution Channel
    • 9.2.8. By Country
  • 9.3. Asia-Pacific: Country Analysis
    • 9.3.1. Japan Nasal Drug Delivery Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Drug Type
        • 9.3.1.2.2. By Dosage Form
        • 9.3.1.2.3. By Container Type
        • 9.3.1.2.4. By Basis of System
        • 9.3.1.2.5. By Therapeutic Applications
        • 9.3.1.2.6. By End User
        • 9.3.1.2.7. By Distribution Channel
    • 9.3.2. China Nasal Drug Delivery Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Drug Type
        • 9.3.2.2.2. By Dosage Form
        • 9.3.2.2.3. By Container Type
        • 9.3.2.2.4. By Basis of System
        • 9.3.2.2.5. By Therapeutic Applications
        • 9.3.2.2.6. By End User
        • 9.3.2.2.7. By Distribution Channel
    • 9.3.3. India Nasal Drug Delivery Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Drug Type
        • 9.3.3.2.2. By Dosage Form
        • 9.3.3.2.3. By Container Type
        • 9.3.3.2.4. By Basis of System
        • 9.3.3.2.5. By Therapeutic Applications
        • 9.3.3.2.6. By End User
        • 9.3.3.2.7. By Distribution Channel
    • 9.3.4. South Korea Nasal Drug Delivery Market Outlook
      • 9.3.4.1. Market Size & Forecast
        • 9.3.4.1.1. By Value
      • 9.3.4.2. Market Share & Forecast
        • 9.3.4.2.1. By Drug Type
        • 9.3.4.2.2. By Dosage Form
        • 9.3.4.2.3. By Container Type
        • 9.3.4.2.4. By Basis of System
        • 9.3.4.2.5. By Therapeutic Applications
        • 9.3.4.2.6. By End User
        • 9.3.4.2.7. By Distribution Channel
    • 9.3.5. Australia Nasal Drug Delivery Market Outlook
      • 9.3.5.1. Market Size & Forecast
        • 9.3.5.1.1. By Value
      • 9.3.5.2. Market Share & Forecast
        • 9.3.5.2.1. By Drug Type
        • 9.3.5.2.2. By Dosage Form
        • 9.3.5.2.3. By Container Type
        • 9.3.5.2.4. By Basis of System
        • 9.3.5.2.5. By Therapeutic Applications
        • 9.3.5.2.6. By End User
        • 9.3.5.2.7. By Distribution Channel

10. South America Nasal Drug Delivery Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Drug Type
    • 10.2.2. By Dosage Form
    • 10.2.3. By Container Type
    • 10.2.4. By Basis of System
    • 10.2.5. By Therapeutic Applications
    • 10.2.6. By End User
    • 10.2.7. By Distribution Channel
    • 10.2.8. By Country
  • 10.3. South America: Country Analysis
    • 10.3.1. Brazil Nasal Drug Delivery Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Drug Type
        • 10.3.1.2.2. By Dosage Form
        • 10.3.1.2.3. By Container Type
        • 10.3.1.2.4. By Basis of System
        • 10.3.1.2.5. By Therapeutic Applications
        • 10.3.1.2.6. By End User
        • 10.3.1.2.7. By Distribution Channel
    • 10.3.2. Argentina Nasal Drug Delivery Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Drug Type
        • 10.3.2.2.2. By Dosage Form
        • 10.3.2.2.3. By Container Type
        • 10.3.2.2.4. By Basis of System
        • 10.3.2.2.5. By Therapeutic Applications
        • 10.3.2.2.6. By End User
        • 10.3.2.2.7. By Distribution Channel
    • 10.3.3. Colombia Nasal Drug Delivery Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Drug Type
        • 10.3.3.2.2. By Dosage Form
        • 10.3.3.2.3. By Container Type
        • 10.3.3.2.4. By Basis of System
        • 10.3.3.2.5. By Therapeutic Applications
        • 10.3.3.2.6. By End User
        • 10.3.3.2.7. By Distribution Channel

11. Middle East and Africa Nasal Drug Delivery Market Outlook

  • 11.1. Market Size & Forecast
    • 11.1.1. By Value
  • 11.2. Market Share & Forecast
    • 11.2.1. By Drug Type
    • 11.2.2. By Dosage Form
    • 11.2.3. By Container Type
    • 11.2.4. By Basis of System
    • 11.2.5. By Therapeutic Applications
    • 11.2.6. By End User
    • 11.2.7. By Distribution Channel
    • 11.2.8. By Country
  • 11.3. MEA: Country Analysis
    • 11.3.1. South Africa Nasal Drug Delivery Market Outlook
      • 11.3.1.1. Market Size & Forecast
        • 11.3.1.1.1. By Value
      • 11.3.1.2. Market Share & Forecast
        • 11.3.1.2.1. By Drug Type
        • 11.3.1.2.2. By Dosage Form
        • 11.3.1.2.3. By Container Type
        • 11.3.1.2.4. By Basis of System
        • 11.3.1.2.5. By Therapeutic Applications
        • 11.3.1.2.6. By End User
        • 11.3.1.2.7. By Distribution Channel
    • 11.3.2. Saudi Arabia Nasal Drug Delivery Market Outlook
      • 11.3.2.1. Market Size & Forecast
        • 11.3.2.1.1. By Value
      • 11.3.2.2. Market Share & Forecast
        • 11.3.2.2.1. By Drug Type
        • 11.3.2.2.2. By Dosage Form
        • 11.3.2.2.3. By Container Type
        • 11.3.2.2.4. By Basis of System
        • 11.3.2.2.5. By Therapeutic Applications
        • 11.3.2.2.6. By End User
        • 11.3.2.2.7. By Distribution Channel
    • 11.3.3. UAE Nasal Drug Delivery Market Outlook
      • 11.3.3.1. Market Size & Forecast
        • 11.3.3.1.1. By Value
      • 11.3.3.2. Market Share & Forecast
        • 11.3.3.2.1. By Drug Type
        • 11.3.3.2.2. By Dosage Form
        • 11.3.3.2.3. By Container Type
        • 11.3.3.2.4. By Basis of System
        • 11.3.3.2.5. By Therapeutic Applications
        • 11.3.3.2.6. By End User
        • 11.3.3.2.7. By Distribution Channel

12. Market Dynamics

  • 12.1. Drivers
  • 12.2. Challenges

13. Market Trends & Developments

14. Competitive Landscape

  • 14.1. Competition Outlook
  • 14.2. Players Profiled (Leading Companies)
    • 14.2.1. GlaxoSmithKline Plc.
    • 14.2.2. Pfizer, Inc.
    • 14.2.3. AstraZeneca PLC
    • 14.2.4. Novartis AG
    • 14.2.5. Becton Dickson & Company
    • 14.2.6. Promius Pharma LLC
    • 14.2.7. 3M Company
    • 14.2.8. Johnson & Johnson Services, Inc.
    • 14.2.9. Sanofi S.A.
    • 14.2.10. Merck & Co., Inc.
    • 14.2.11. Cadila Pharmaceuticals Ltd.
    • 14.2.12. Aegis Therapeutics, LLC
    • 14.2.13. B.F. Ascher & Company, Inc.
    • 14.2.14. ENT Technologies Pty. Ltd.
    • 14.2.15. AptarGroup, Inc.

15. Strategic Recommendations

16. About Us & Disclaimer

List of Figures

  • Figure 1: Global Nasal Drug Delivery Market Size, By Value (USD Billion), 2016-2026F
  • Figure 2: Global Nasal Drug Delivery Market Share, By Drug Type, By Value,2016-2026F
  • Figure 3: Global Nasal Drug Delivery Market Share, By Dosage Form, By Value, 2016-2026F
  • Figure 4: Global Nasal Drug Delivery Market Share, By Container Type, By Value, 2016-2026F
  • Figure 5: Global Nasal Drug Delivery Market Share, By Basis of System, By Value, 2016-2026F
  • Figure 6: Global Nasal Drug Delivery Market Share, By Therapeutic Application, By Value, 2016-2026F
  • Figure 7: Global Nasal Drug Delivery Market Share, By End User, By Value, 2016-2026F
  • Figure 8: Global Nasal Drug Delivery Market Share, By Distribution Channel, By Value, 2016-2026F
  • Figure 9: Global Nasal Drug Delivery Market Share, By Company, 2020
  • Figure 10: Global Nasal Drug Delivery Market Share, By Region, 2016-2026F
  • Figure 11: Global Nasal Drug Delivery Market Share, Product Market Map, By Value, 2016-2026F
  • Figure 12: North America Nasal Drug Delivery Market Size, By Value (USD Billion), 2016-2026F
  • Figure 13: North America Nasal Drug Delivery Market Share, By Drug Type, By Value,2016-2026F
  • Figure 14: North America Nasal Drug Delivery Market Share, By Dosage Form, By Value, 2016-2026F
  • Figure 15: North America Nasal Drug Delivery Market Share, By Container Type, By Value, 2016-2026F
  • Figure 16: North America Nasal Drug Delivery Market Share, By Basis of System, By Value, 2016-2026F
  • Figure 17: North America Nasal Drug Delivery Market Share, By Therapeutic Application, By Value, 2016-2026F
  • Figure 18: North America Nasal Drug Delivery Market Share, By End User, By Value, 2016-2026F
  • Figure 19: North America Nasal Drug Delivery Market Share, By Distribution Channel, By Value, 2016-2026F
  • Figure 20: North America Nasal Drug Delivery, By Country, By Value, 2016-2026F
  • Figure 21: United States Nasal Drug Delivery Market Size, By Value (USD Billion), 2016-2026F
  • Figure 22: United States Nasal Drug Delivery Market Share, By Drug Type, By Value,2016-2026F
  • Figure 23: United States Nasal Drug Delivery Market Share, By Dosage Form, By Value, 2016-2026F
  • Figure 24: United States Nasal Drug Delivery Market Share, By Container Type, By Value, 2016-2026F
  • Figure 25: United States Nasal Drug Delivery Market Share, By Basis of System, By Value, 2016-2026F
  • Figure 26: United States Nasal Drug Delivery Market Share, By Therapeutic Application, By Value, 2016-2026F
  • Figure 27: United States Nasal Drug Delivery Market Share, By End User, By Value, 2016-2026F
  • Figure 28: United States Nasal Drug Delivery Market Share, By Distribution Channel, By Value, 2016-2026F
  • Figure 29: Mexico Nasal Drug Delivery Market Size, By Value (USD Billion), 2016-2026F
  • Figure 30: Mexico Nasal Drug Delivery Market Share, By Drug Type, By Value, 2016-2026F
  • Figure 31: Mexico Nasal Drug Delivery Market Share, By Dosage Form, By Value, 2016-2026F
  • Figure 32: Mexico Nasal Drug Delivery Market Share, By Container Type, By Value, 2016-2026F
  • Figure 33: Mexico Nasal Drug Delivery Market Share, By Basis of System, By Value, 2016-2026F
  • Figure 34: Mexico Nasal Drug Delivery Market Share, By Therapeutic Application, By Value, 2016-2026F
  • Figure 35: Mexico Nasal Drug Delivery Market Share, By End User, By Value, 2016-2026F
  • Figure 36: Mexico Nasal Drug Delivery Market Share, By Distribution Channel, By Value, 2016-2026F
  • Figure 37: Canada Nasal Drug Delivery Market Size, By Value (USD Billion), 2016-2026F
  • Figure 38: Canada Nasal Drug Delivery Market Share, By Drug Type, By Value,2016-2026F
  • Figure 39: Canada Nasal Drug Delivery Market Share, By Dosage Form, By Value, 2016-2026F
  • Figure 40: Canada Nasal Drug Delivery Market Share, By Container Type, By Value, 2016-2026F
  • Figure 41: Canada Nasal Drug Delivery Market Share, By Basis of System, By Value, 2016-2026F
  • Figure 42: Canada Nasal Drug Delivery Market Share, By Therapeutic Application, By Value, 2016-2026F
  • Figure 43: Canada Nasal Drug Delivery Market Share, By End User, By Value, 2016-2026F
  • Figure 44: Canada Nasal Drug Delivery Market Share, By Distribution Channel, By Value, 2016-2026F
  • Figure 45: Europe Nasal Drug Delivery Market Size, By Value (USD Billion), 2016-2026F
  • Figure 46: Europe Nasal Drug Delivery Market Share, By Drug Type, By Value,2016-2026F
  • Figure 47: Europe Nasal Drug Delivery Market Share, By Dosage Form, By Value, 2016-2026F
  • Figure 48: Europe Nasal Drug Delivery Market Share, By Container Type, By Value, 2016-2026F
  • Figure 49: Europe Nasal Drug Delivery Market Share, By Basis of System, By Value, 2016-2026F
  • Figure 50: Europe Nasal Drug Delivery Market Share, By Therapeutic Application, By Value, 2016-2026F
  • Figure 51: Europe Nasal Drug Delivery Market Share, By End User, By Value, 2016-2026F
  • Figure 52: Europe Nasal Drug Delivery Market Share, By Distribution Channel, By Value, 2016-2026F
  • Figure 53: Europe Nasal Drug Delivery, By Country, By Value, 2016-2026F
  • Figure 54: Germany Nasal Drug Delivery Market Size, By Value (USD Billion), 2016-2026F
  • Figure 55: Germany Nasal Drug Delivery Market Share, By Drug Type, By Value,2016-2026F
  • Figure 56: Germany Nasal Drug Delivery Market Share, By Dosage Form, By Value, 2016-2026F
  • Figure 57: Germany Nasal Drug Delivery Market Share, By Container Type, By Value, 2016-2026F
  • Figure 58: Germany Nasal Drug Delivery Market Share, By Basis of System, By Value, 2016-2026F
  • Figure 59: Germany Nasal Drug Delivery Market Share, By Therapeutic Application, By Value, 2016-2026F
  • Figure 60: Germany Nasal Drug Delivery Market Share, By End User, By Value, 2016-2026F
  • Figure 61: Germany Nasal Drug Delivery Market Share, By Distribution Channel, By Value, 2016-2026F
  • Figure 62: France Nasal Drug Delivery Market Size, By Value (USD Billion), 2016-2026F
  • Figure 63: France Nasal Drug Delivery Market Share, By Drug Type, By Value,2016-2026F
  • Figure 64: France Nasal Drug Delivery Market Share, By Dosage Form, By Value, 2016-2026F
  • Figure 65: France Nasal Drug Delivery Market Share, By Container Type, By Value, 2016-2026F
  • Figure 66: France Nasal Drug Delivery Market Share, By Basis of System, By Value, 2016-2026F
  • Figure 67: France Nasal Drug Delivery Market Share, By Therapeutic Application, By Value, 2016-2026F
  • Figure 68: France Nasal Drug Delivery Market Share, By End User, By Value, 2016-2026F
  • Figure 69: France Nasal Drug Delivery Market Share, By Distribution Channel, By Value, 2016-2026F
  • Figure 70: United Kingdom Nasal Drug Delivery Market Size, By Value (USD Billion), 2016-2026F
  • Figure 71: United Kingdom Nasal Drug Delivery Market Share, By Drug Type, By Value,2016-2026F
  • Figure 72: United Kingdom Nasal Drug Delivery Market Share, By Dosage Form, By Value, 2016-2026F
  • Figure 73: United Kingdom Nasal Drug Delivery Market Share, By Container Type, By Value, 2016-2026F
  • Figure 74: United Kingdom Nasal Drug Delivery Market Share, By Basis of System, By Value, 2016-2026F
  • Figure 75: United Kingdom Nasal Drug Delivery Market Share, By Therapeutic Application, By Value, 2016-2026F
  • Figure 76: United Kingdom Nasal Drug Delivery Market Share, By End User, By Value, 2016-2026F
  • Figure 77: United Kingdom Nasal Drug Delivery Market Share, By Distribution Channel, By Value, 2016-2026F
  • Figure 78: Italy Nasal Drug Delivery Market Size, By Value (USD Billion), 2016-2026F
  • Figure 79: Italy Nasal Drug Delivery Market Share, By Drug Type, By Value,2016-2026F
  • Figure 80: Italy Nasal Drug Delivery Market Share, By Dosage Form, By Value, 2016-2026F
  • Figure 81: Italy Nasal Drug Delivery Market Share, By Container Type, By Value, 2016-2026F
  • Figure 82: Italy Nasal Drug Delivery Market Share, By Basis of System, By Value, 2016-2026F
  • Figure 83: Italy Nasal Drug Delivery Market Share, By Therapeutic Application, By Value, 2016-2026F
  • Figure 84: Italy Nasal Drug Delivery Market Share, By End User, By Value, 2016-2026F
  • Figure 85: Italy Nasal Drug Delivery Market Share, By Distribution Channel, By Value, 2016-2026F
  • Figure 86: Spain Nasal Drug Delivery Market Size, By Value (USD Billion), 2016-2026F
  • Figure 87: Spain Nasal Drug Delivery Market Share, By Drug Type, By Value,2016-2026F
  • Figure 88: Spain Nasal Drug Delivery Market Share, By Dosage Form, By Value, 2016-2026F
  • Figure 89: Spain Nasal Drug Delivery Market Share, By Container Type, By Value, 2016-2026F
  • Figure 90: Spain Nasal Drug Delivery Market Share, By Basis of System, By Value, 2016-2026F
  • Figure 91: Spain Nasal Drug Delivery Market Share, By Therapeutic Application, By Value, 2016-2026F
  • Figure 92: Spain Nasal Drug Delivery Market Share, By End User, By Value, 2016-2026F
  • Figure 93: Spain Nasal Drug Delivery Market Share, By Distribution Channel, By Value, 2016-2026F
  • Figure 94: Asia-Pacific Nasal Drug Delivery Market Size, By Value (USD Billion), 2016-2026F
  • Figure 95: Asia-Pacific Nasal Drug Delivery Market Share, By Drug Type, By Value,2016-2026F
  • Figure 96: Asia-Pacific Nasal Drug Delivery Market Share, By Dosage Form, By Value, 2016-2026F
  • Figure 97: Asia-Pacific Nasal Drug Delivery Market Share, By Container Type, By Value, 2016-2026F
  • Figure 98: Asia-Pacific Nasal Drug Delivery Market Share, By Basis of System, By Value, 2016-2026F
  • Figure 99: Asia-Pacific Nasal Drug Delivery Market Share, By Therapeutic Application, By Value, 2016-2026F
  • Figure 100: Asia-Pacific Nasal Drug Delivery Market Share, By End User, By Value, 2016-2026F
  • Figure 101: Asia-Pacific Nasal Drug Delivery Market Share, By Distribution Channel, By Value, 2016-2026F
  • Figure 102: Asia-Pacific Nasal Drug Delivery Market Share, By Country, By Value, 2016-2026F
  • Figure 103: Japan Nasal Drug Delivery Market Size, By Value (USD Billion), 2016-2026F
  • Figure 104: Japan Nasal Drug Delivery Market Share, By Drug Type, By Value,2016-2026F
  • Figure 105: Japan Nasal Drug Delivery Market Share, By Dosage Form, By Value, 2016-2026F
  • Figure 106: Japan Nasal Drug Delivery Market Share, By Container Type, By Value, 2016-2026F
  • Figure 107: Japan Nasal Drug Delivery Market Share, By Basis of System, By Value, 2016-2026F
  • Figure 108: Japan Nasal Drug Delivery Market Share, By Therapeutic Application, By Value, 2016-2026F
  • Figure 109: Japan Nasal Drug Delivery Market Share, By End User, By Value, 2016-2026F
  • Figure 110: Japan Nasal Drug Delivery Market Share, By Distribution Channel, By Value, 2016-2026F
  • Figure 111: China Nasal Drug Delivery Market Size, By Value (USD Billion), 2016-2026F
  • Figure 112: China Nasal Drug Delivery Market Share, By Drug Type, By Value,2016-2026F
  • Figure 113: China Nasal Drug Delivery Market Share, By Dosage Form, By Value, 2016-2026F
  • Figure 114: China Nasal Drug Delivery Market Share, By Container Type, By Value, 2016-2026F
  • Figure 115: China Nasal Drug Delivery Market Share, By Basis of System, By Value, 2016-2026F
  • Figure 116: China Nasal Drug Delivery Market Share, By Therapeutic Application, By Value, 2016-2026F
  • Figure 117: China Nasal Drug Delivery Market Share, By End User, By Value, 2016-2026F
  • Figure 118: China Nasal Drug Delivery Market Share, By Distribution Channel, By Value, 2016-2026F
  • Figure 119: India Nasal Drug Delivery Market Size, By Value (USD Billion), 2016-2026F
  • Figure 120: India Nasal Drug Delivery Market Share, By Drug Type, By Value,2016-2026F
  • Figure 121: India Nasal Drug Delivery Market Share, By Dosage Form, By Value, 2016-2026F
  • Figure 122: India Nasal Drug Delivery Market Share, By Container Type, By Value, 2016-2026F
  • Figure 123: India Nasal Drug Delivery Market Share, By Basis of System, By Value, 2016-2026F
  • Figure 124: India Nasal Drug Delivery Market Share, By Therapeutic Application, By Value, 2016-2026F
  • Figure 125: India Nasal Drug Delivery Market Share, By End User, By Value, 2016-2026F
  • Figure 126: India Nasal Drug Delivery Market Share, By Distribution Channel, By Value, 2016-2026F
  • Figure 127: South Korea Nasal Drug Delivery Market Size, By Value (USD Billion), 2016-2026F
  • Figure 128: South Korea Nasal Drug Delivery Market Share, By Drug Type, By Value,2016-2026F
  • Figure 129: South Korea Nasal Drug Delivery Market Share, By Dosage Form, By Value, 2016-2026F
  • Figure 130: South Korea Nasal Drug Delivery Market Share, By Container Type, By Value, 2016-2026F
  • Figure 131: South Korea Nasal Drug Delivery Market Share, By Basis of System, By Value, 2016-2026F
  • Figure 132: South Korea Nasal Drug Delivery Market Share, By Therapeutic Application, By Value, 2016-2026F
  • Figure 133: South Korea Nasal Drug Delivery Market Share, By End User, By Value, 2016-2026F
  • Figure 134: South Korea Nasal Drug Delivery Market Share, By Distribution Channel, By Value, 2016-2026F
  • Figure 135: Australia Nasal Drug Delivery Market Size, By Value (USD Billion), 2016-2026F
  • Figure 136: Australia Nasal Drug Delivery Market Share, By Drug Type, By Value,2016-2026F
  • Figure 137: Australia Nasal Drug Delivery Market Share, By Dosage Form, By Value, 2016-2026F
  • Figure 138: Australia Nasal Drug Delivery Market Share, By Container Type, By Value, 2016-2026F
  • Figure 139: Australia Nasal Drug Delivery Market Share, By Basis of System, By Value, 2016-2026F
  • Figure 140: Australia Nasal Drug Delivery Market Share, By Therapeutic Application, By Value, 2016-2026F
  • Figure 141: Australia Nasal Drug Delivery Market Share, By End User, By Value, 2016-2026F
  • Figure 142: Australia Nasal Drug Delivery Market Share, By Distribution Channel, By Value, 2016-2026F
  • Figure 143: South America Nasal Drug Delivery Market Size, By Value (USD Billion), 2016-2026F
  • Figure 144: South America Nasal Drug Delivery Market Share, By Drug Type, By Value,2016-2026F
  • Figure 145: South America Nasal Drug Delivery Market Share, By Dosage Form, By Value, 2016-2026F
  • Figure 146: South America Nasal Drug Delivery Market Share, By Container Type, By Value, 2016-2026F
  • Figure 147: South America Nasal Drug Delivery Market Share, By Basis of System, By Value, 2016-2026F
  • Figure 148: South America Nasal Drug Delivery Market Share, By Therapeutic Application, By Value, 2016-2026F
  • Figure 149: South America Nasal Drug Delivery Market Share, By End User, By Value, 2016-2026F
  • Figure 150: South America Nasal Drug Delivery Market Share, By Distribution Channel, By Value, 2016-2026F
  • Figure 151: South America Nasal Drug Delivery Market Share, By Country, By Value, 2016-2026F
  • Figure 152: Brazil Nasal Drug Delivery Market Size, By Value (USD Billion), 2016-2026F
  • Figure 153: Brazil Nasal Drug Delivery Market Share, By Drug Type, By Value,2016-2026F
  • Figure 154: Brazil Nasal Drug Delivery Market Share, By Dosage Form, By Value, 2016-2026F
  • Figure 155: Brazil Nasal Drug Delivery Market Share, By Container Type, By Value, 2016-2026F
  • Figure 156: Brazil Nasal Drug Delivery Market Share, By Basis of System, By Value, 2016-2026F
  • Figure 157: Brazil Nasal Drug Delivery Market Share, By Therapeutic Application, By Value, 2016-2026F
  • Figure 158: Brazil Nasal Drug Delivery Market Share, By End User, By Value, 2016-2026F
  • Figure 159: Brazil Nasal Drug Delivery Market Share, By Distribution Channel, By Value, 2016-2026F
  • Figure 160: Argentina Nasal Drug Delivery Market Size, By Value (USD Billion), 2016-2026F
  • Figure 161: Argentina Nasal Drug Delivery Market Share, By Drug Type, By Value,2016-2026F
  • Figure 162: Argentina Nasal Drug Delivery Market Share, By Dosage Form, By Value, 2016-2026F
  • Figure 163: Argentina Nasal Drug Delivery Market Share, By Container Type, By Value, 2016-2026F
  • Figure 164: Argentina Nasal Drug Delivery Market Share, By Basis of System, By Value, 2016-2026F
  • Figure 165: Argentina Nasal Drug Delivery Market Share, By Therapeutic Application, By Value, 2016-2026F
  • Figure 166: Argentina Nasal Drug Delivery Market Share, By End User, By Value, 2016-2026F
  • Figure 167: Argentina Nasal Drug Delivery Market Share, By Distribution Channel, By Value, 2016-2026F
  • Figure 168: Colombia Nasal Drug Delivery Market Size, By Value (USD Billion), 2016-2026F
  • Figure 169: Colombia Nasal Drug Delivery Market Share, By Drug Type, By Value,2016-2026F
  • Figure 170: Colombia Nasal Drug Delivery Market Share, By Dosage Form, By Value, 2016-2026F
  • Figure 171: Colombia Nasal Drug Delivery Market Share, By Container Type, By Value, 2016-2026F
  • Figure 172: Colombia Nasal Drug Delivery Market Share, By Basis of System, By Value, 2016-2026F
  • Figure 173: Colombia Nasal Drug Delivery Market Share, By Therapeutic Application, By Value, 2016-2026F
  • Figure 174: Colombia Nasal Drug Delivery Market Share, By End User, By Value, 2016-2026F
  • Figure 175: Colombia Nasal Drug Delivery Market Share, By Distribution Channel, By Value, 2016-2026F
  • Figure 176: Middle East and Africa Nasal Drug Delivery Market Size, By Value (USD Billion), 2016-2026F
  • Figure 177: Middle East and Africa Nasal Drug Delivery Market Share, By Drug Type, By Value,2016-2026F
  • Figure 178: Middle East and Africa Nasal Drug Delivery Market Share, By Dosage Form, By Value, 2016-2026F
  • Figure 179: Middle East and Africa Nasal Drug Delivery Market Share, By Container Type, By Value, 2016-2026F
  • Figure 180: Middle East and Africa Nasal Drug Delivery Market Share, By Basis of System, By Value, 2016-2026F
  • Figure 181: Middle East Nasal Drug Delivery Market Share, By Therapeutic Application, By Value, 2016-2026F
  • Figure 182: Middle East Nasal Drug Delivery Market Share, By End User, By Value, 2016-2026F
  • Figure 183: Middle East Nasal Drug Delivery Market Share, By Distribution Channel, By Value, 2016-2026F
  • Figure 184: Middle East and Africa Nasal Drug Delivery, By Country, By Value, 2016-2026F
  • Figure 185: South Africa Nasal Drug Delivery Market Size, By Value (USD Billion), 2016-2026F
  • Figure 186: South Africa Nasal Drug Delivery Market Share, By Drug Type, By Value,2016-2026F
  • Figure 187: South Africa Nasal Drug Delivery Market Share, By Dosage Form, By Value, 2016-2026F
  • Figure 188: South Africa Nasal Drug Delivery Market Share, By Container Type, By Value, 2016-2026F
  • Figure 189: South Africa Nasal Drug Delivery Market Share, By Basis of System, By Value, 2016-2026F
  • Figure 190: South Africa Nasal Drug Delivery Market Share, By Therapeutic Application, By Value, 2016-2026F
  • Figure 191: South Africa Nasal Drug Delivery Market Share, By End User, By Value, 2016-2026F
  • Figure 192: South Africa Nasal Drug Delivery Market Share, By Distribution Channel, By Value, 2016-2026F
  • Figure 193: Saudi Arabia Nasal Drug Delivery Market Size, By Value (USD Billion), 2016-2026F
  • Figure 194: Saudi Arabia Nasal Drug Delivery Market Share, By Drug Type, By Value,2016-2026F
  • Figure 195: Saudi Arabia Nasal Drug Delivery Market Share, By Dosage Form, By Value, 2016-2026F
  • Figure 196: Saudi Arabia Nasal Drug Delivery Market Share, By Container Type, By Value, 2016-2026F
  • Figure 197: Saudi Arabia Nasal Drug Delivery Market Share, By Basis of System, By Value, 2016-2026F
  • Figure 198: Saudi Arabia Nasal Drug Delivery Market Share, By Therapeutic Application, By Value, 2016-2026F
  • Figure 199: Saudi Arabia Nasal Drug Delivery Market Share, By End User, By Value, 2016-2026F
  • Figure 200: Saudi Arabia Nasal Drug Delivery Market Share, By Distribution Channel, By Value, 2016-2026F
  • Figure 201: UAE Nasal Drug Delivery Market Size, By Value (USD Billion), 2016-2026F
  • Figure 202: UAE Nasal Drug Delivery Market Share, By Drug Type, By Value,2016-2026F
  • Figure 203: UAE Nasal Drug Delivery Market Share, By Dosage Form, By Value, 2016-2026F
  • Figure 204: UAE Nasal Drug Delivery Market Share, By Container Type, By Value, 2016-2026F
  • Figure 205: UAE Nasal Drug Delivery Market Share, By Basis of System, By Value, 2016-2026F
  • Figure 206: UAE Nasal Drug Delivery Market Share, By Therapeutic Application, By Value, 2016-2026F
  • Figure 207: UAE Nasal Drug Delivery Market Share, By End User, By Value, 2016-2026F
  • Figure 208: UAE Nasal Drug Delivery Market Share, By Distribution Channel, By Value, 2016-2026F